We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

171 hedge funds and large institutions have $1.81B invested in NEVRO CORP. in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more call options, than puts

Call options by funds: $29.9M | Put options by funds: $16.4M

35% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 46

11% less funds holding

Funds holding: 192171 (-21)

33% less capital invested

Capital invested by funds: $2.7B → $1.81B (-$883M)

38% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 53

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
171
Holders Change
-21
Holders Change %
-10.94%
% of All Funds
3.91%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
33
Increased
62
Reduced
46
Closed
53
Calls
$29.9M
Puts
$16.4M
Net Calls
+$13.4M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
AAMU
51
Amundi Asset Management US
Massachusetts
$4.26M -$11M -176,653 -70%
TCM
52
Tekla Capital Management
Massachusetts
$3.92M +$986K +15,770 +30%
Canada Pension Plan Investment Board
53
Canada Pension Plan Investment Board
Ontario, Canada
$3.68M +$825K +13,200 +26%
TA
54
Teachers Advisors
New York
$3.47M -$8.12M -129,967 -68%
MOACM
55
Mutual of America Capital Management
New York
$3.47M -$1.06M -16,987 -22%
BIM
56
Bogle Investment Management
Massachusetts
$2.94M +$3.22M +51,588 New
PC
57
Polar Capital
United Kingdom
$2.85M +$625K +10,000 +25%
Barclays
58
Barclays
United Kingdom
$2.83M +$2.97M +47,498 +2,228%
PP
59
PDT Partners
New York
$2.82M -$194K -3,098 -6%
Balyasny Asset Management
60
Balyasny Asset Management
Illinois
$2.7M +$2.74M +43,837 +1,262%
Swiss National Bank
61
Swiss National Bank
Switzerland
$2.66M
SCM
62
Sio Capital Management
New York
$2.57M +$2.82M +45,091 New
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$2.53M -$9.06K -145 -0.3%
RIG
64
Roosevelt Investment Group
New York
$2.37M +$39.8K +636 +2%
Los Angeles Capital Management
65
Los Angeles Capital Management
California
$2.25M +$2.46M +39,381 New
DekaBank Deutsche Girozentrale
66
DekaBank Deutsche Girozentrale
Germany
$2.17M +$750K +12,000 +57%
CGI
67
Comgest Global Investors
France
$2.06M -$513K -8,200 -18%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$1.93M -$5.11M -81,677 -71%
DTL
69
Dynamic Technology Lab
Singapore
$1.93M +$2.11M +33,784 New
SEC
70
Seven Eight Capital
New York
$1.91M +$2.09M +33,418 New
PCM
71
Portolan Capital Management
Massachusetts
$1.8M -$93.8K -1,501 -5%
ACM
72
Asymmetry Capital Management
California
$1.79M +$1.96M +31,379 New
PPA
73
Parametric Portfolio Associates
Washington
$1.71M -$12.8K -205 -0.7%
Marshall Wace
74
Marshall Wace
United Kingdom
$1.71M +$1.88M +30,018 New
GH
75
GAM Holding
Switzerland
$1.61M -$2.52M -40,300 -59%

NVRO Hedge Fund Activity: Q3 2018 in Review

171 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2018, worth a combined $1.81B — down 33% from $2.7B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of NVRO and 33 opened new positions — a net loss of 20 holders — while 46 trimmed existing stakes and 62 added.

The largest buyer was Point72 Asset Management, adding an estimated $87.9M. The largest seller was Wells Fargo, cutting an estimated $72.2M.

  • 171 institutional investors held NEVRO CORP. (NVRO) as of Q3 2018, down from 192 in Q2 2018.
  • Funds reported $1.81B of NEVRO CORP. stock for Q3 2018, down 33% quarter-over-quarter.
  • 33 funds opened new NEVRO CORP. positions in Q3 2018 and 53 closed out, a net change of -20 holders.
  • The largest NEVRO CORP. buyer in Q3 2018 was Point72 Asset Management, an estimated $87.9M added.
  • The largest NEVRO CORP. seller in Q3 2018 was Wells Fargo, an estimated $72.2M sold.

Based on aggregated 13F filings for Q3 2018.